Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Chuard

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Hepatology|March 26, 2005
Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis CBarbara Broers, Beat Helbling, Anne François, et al.
Swiss Medical Weekly|July 15, 2020
Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area - a retrospective cohort studyCharlotte Pellaud, Gael Grandmaison, Hoa Phong Pham Huu Thien, et al.
Plos One|June 16, 2016
Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired PneumoniaNicolas Garin, Garance Felix, Christian Chuard, et al.
JAMA Internal Medicine|October 7, 2014
β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trialNicolas Garin, Daniel Genné, Sebastian Carballo, et al.
Swiss Medical Weekly|July 22, 2010
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison studyJean-Jacques Gonvers, Markus H Heim, Matthias Cavassini, et al.
Revue Medicale Suisse|April 13, 2022
[Methicillin-resistant <i>Staphylococcus aureus</i>: 15 years of molecular epidemiology in Western Switzerland]Dominique S Blanc, Bruno Grandbastien, Frank Bally, et al.
European Journal of Immunology|October 30, 2008
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replicationDonatella Ciuffreda, Denis Comte, Matthias Cavassini, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Hepatology|March 26, 2005
Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis CBarbara Broers, Beat Helbling, Anne François, et al.
Swiss Medical Weekly|July 15, 2020
Characteristics, comorbidities, 30-day outcome and in-hospital mortality of patients hospitalised with COVID-19 in a Swiss area - a retrospective cohort studyCharlotte Pellaud, Gael Grandmaison, Hoa Phong Pham Huu Thien, et al.
Plos One|June 16, 2016
Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired PneumoniaNicolas Garin, Garance Felix, Christian Chuard, et al.
JAMA Internal Medicine|October 7, 2014
β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trialNicolas Garin, Daniel Genné, Sebastian Carballo, et al.
Swiss Medical Weekly|July 22, 2010
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison studyJean-Jacques Gonvers, Markus H Heim, Matthias Cavassini, et al.
Revue Medicale Suisse|April 13, 2022
[Methicillin-resistant <i>Staphylococcus aureus</i>: 15 years of molecular epidemiology in Western Switzerland]Dominique S Blanc, Bruno Grandbastien, Frank Bally, et al.
European Journal of Immunology|October 30, 2008
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replicationDonatella Ciuffreda, Denis Comte, Matthias Cavassini, et al.
Pageof 4